Universal Fe/Mn Nanoadjuvant with T1/T2 MRI Self-Navigation and Gas Generation for Ideal Vaccines with Precise Tracking.
Wei HuangSujiang ShiYalin JiangYuan TianYing WangDan JiangLigeng XuTianfeng ChenPublished in: ACS nano (2023)
Because of the distinguished properties between nanovaccine and traditional vaccine, the precise guidelines for nanovaccines with an optimal vaccination strategy to induce ideal immunities are greatly desired for combating major diseases, including cancer and infections. Herein, we designed and synthesized a self-navigating nanoadjuvant composed of Fe-doped manganese carbonate and its nanovaccine via a facile method. First, the degradation of the nanoadjuvant under acidic milieu of immune cells in lymph nodes would generate T1 and T2 MR imaging (MRI) signals to reflect the transformation dynamics of the nanovaccine and inform us when the next vaccination needed. Under this guideline, nanovaccines with a precise vaccination strategy triggered robust antigen-specific immune responses and immunological memory to effectively prevent ovalbumin (OVA)-expressing melanoma relapse by activating dendritic cells via a stimulator of interferon genes (STING) signaling pathway and inducing antigen cross-presentation by shaping lysosome integrity with CO 2 generation and upregulating transporter associated antigen processing 1 (TAP-1) transporter. This study provides a universal nanoadjuvant with imaging self-guidance, immunopotentiating, and cross-priming activities for developing precise vaccines with an optimal immunization strategy to combat major diseases.
Keyphrases
- dendritic cells
- immune response
- signaling pathway
- contrast enhanced
- metal organic framework
- lymph node
- magnetic resonance imaging
- quantum dots
- visible light
- high resolution
- regulatory t cells
- computed tomography
- room temperature
- diffusion weighted imaging
- pi k akt
- highly efficient
- papillary thyroid
- genome wide
- induced apoptosis
- squamous cell carcinoma
- working memory
- case report
- clinical practice
- early stage
- neoadjuvant chemotherapy
- squamous cell
- oxidative stress
- reduced graphene oxide
- oxide nanoparticles
- skin cancer